Meta-analysis of SUMO1

BMC Research Notes

Volumn 1, Issue , 2008, Pages

  Wilson, Brian J ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955800411     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-1-60     Document Type: Article

References (17)

1. Oncomine, http://www.oncomine.org
2. Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis. BJ Wilson V Giguere, BMC Genomics 2007 8 419 10.1186/1471-2164-8-419 18005418
3. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. BJ Wilson V Giguere, Mol Cancer 2008 7 49 18533032 10.1186/1476-4598-7-49 (Pubitemid 351891429)
4. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. S Muller MJ Matunis A Dejean, Embo J 1998 17 61 70 9427741 10.1093/emboj/17.1.61 (Pubitemid 28041048)
5. Sumoylation increases HIF-1alpha stability and its transcriptional activity. SH Bae JW Jeong JA Park SH Kim MK Bae SJ Choi KW Kim, Biochem Biophys Res Commun 2004 324 394 400 10.1016/j.bbrc.2004.09.068 15465032
6. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. A Ledl D Schmidt S Muller, Oncogene 2005 24 3810 3818 10.1038/sj.onc.1208539 15806172
7. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Z Deng M Wan G Sui, Mol Cell Biol 2007 27 3780 3792 17353273 10.1128/MCB.01761-06 (Pubitemid 46726185)
8. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. T Sternsdorf K Jensen H Will, J Cell Biol 1997 139 1621 1634 9412458 10.1083/jcb.139.7.1621 (Pubitemid 28079228)
9. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. X Lin M Liang YY Liang FC Brunicardi F Melchior XH Feng, J Biol Chem 2003 278 18714 18719 10.1074/jbc.M302243200 12621041
10. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. E Duprez AJ Saurin JM Desterro V Lallemand-Breitenbach K Howe MN Boddy E Solomon H de The RT Hay PS Freemont, J Cell Sci 1999 112 Pt 3 381 393 9885291
11. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. TT Huang SM Wuerzberger-Davis ZH Wu S Miyamoto, Cell 2003 115 565 576 10.1016/S0092-8674(03)00895-X 14651848
12. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. A Carbia-Nagashima J Gerez C Perez-Castro M Paez-Pereda S Silberstein GK Stalla F Holsboer E Arzt, Cell 2007 131 309 323 10.1016/j.cell.2007.07.044 17956732
13. Mice lacking Dad1, the defender against apoptotic death-1, express abnormal N-linked glycoproteins and undergo increased embryonic apoptosis. NA Hong M Flannery SN Hsieh D Cado R Pedersen A Winoto, Dev Biol 2000 220 76 84 10.1006/dbio.2000.9615 10720432
14. Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas. K Tanaka N Kondoh M Shuda O Matsubara N Imazeki A Ryo T Wakatsuki A Hada N Goseki T Igari K Hatsuse T Aihara S Horiuchi N Yamamoto M Yamamoto, Biochim Biophys Acta 2001 1536 1 12 11335099
15. The DEK protein - an abundant and ubiquitous constituent of mammalian chromatin. T Waldmann I Scholten F Kappes HG Hu R Knippers, Gene 2004 343 1 9 10.1016/j.gene.2004.08.029 15563827
16. p300/CBP-associated factor drives DEK into interchromatin granule clusters. J Cleary KV Sitwala MS Khodadoust RP Kwok N Mor-Vaknin M Cebrat PA Cole DM Markovitz, J Biol Chem 2005 280 31760 31767 10.1074/jbc.M500884200 15987677
17. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. TM Wise-Draper HV Allen EE Jones KB Habash H Matsuo SI Wells, Mol Cell Biol 2006 26 7506 7519 16894028 10.1128/MCB.00430-06 (Pubitemid 44547701)